Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
Sponsor: AbbVie
Summary
This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerability.
Official title: A Phase 1, Randomized, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Emraclidine Following Multiple Ascending Oral Doses in Healthy Elderly Subjects
Key Details
Gender
All
Age Range
65 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-10-08
Completion Date
2026-11
Last Updated
2025-11-10
Healthy Volunteers
Yes
Conditions
Interventions
Emraclidine
Oral tablets
Placebo
Oral tablets
Locations (4)
Altasciences Clinical Los Angeles /ID# 276854
Cypress, California, United States
K2 Medical Research, LLC /ID# 276636
Maitland, Florida, United States
Clinical Pharmacology Of Miami /ID# 276856
Miami, Florida, United States
Acpru /Id# 276996
Grayslake, Illinois, United States